01
Cash & equivalents decreased 6.2%
Cash & equivalents changed -6.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$124.5M→$116.8MComparable → current
· Biological Products, (No Diagnostic Substances)
RESEARCH SNAPSHOTNeumora Therapeutics, Inc.'s latest supported as-filed period reports interest income of $935,000. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed -6.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Debt changed +172.0% from the comparable as-filed period.
Net income changed +18.3% from the comparable as-filed period.
Operating income changed +21.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
NMRA · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001610717-26-000385SEC ↗4Aug 21, 2026Period Aug 20, 20260001610717-26-000384SEC ↗4Aug 21, 2026Period Aug 20, 20260001610717-26-000383SEC ↗4Aug 21, 2026Period Aug 20, 20260001610717-26-000382SEC ↗4Aug 21, 2026Period Aug 20, 20260001610717-26-000381SEC ↗4Aug 19, 2026Period Aug 17, 20260001610717-26-000362SEC ↗10-QAug 14, 2026Period Jun 30, 20260001193125-26-350370SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Aug 21, 2026Filed Aug 21, 2026 | Aurora Daljit SinghSee Remarks | Option ExerciseDirect | 20,553 | $1 | $14,798 | Form 4 ↗ |
| Aug 21, 2026Filed Aug 21, 2026 | Aurora Daljit SinghSee Remarks | Open Market SaleDirect | 20,553 | $2 | $32,780 | Form 4 ↗ |
| Aug 21, 2026Filed Aug 21, 2026 | Aurora Daljit SinghSee Remarks | Option ExerciseIndirect | 21,055 | $1 | $15,160 | Form 4 ↗ |
| Aug 21, 2026Filed Aug 21, 2026 | Aurora Daljit SinghSee Remarks | Open Market SaleIndirect | 21,055 | $2 | $33,600 | Form 4 ↗ |
| Aug 21, 2026Filed Aug 21, 2026 |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Research & development changed -24.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Stock-based compensation changed +0.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001193125-26-350349| Aurora Daljit SinghSee Remarks |
| Option ExerciseDirect |
| 20,553 |
| $0 |
| $0 |
| Form 4 ↗ |
| Aug 21, 2026Filed Aug 21, 2026 | Aurora Daljit SinghSee Remarks | Option ExerciseIndirect | 21,055 | $0 | $0 | Form 4 ↗ |
| Aug 20, 2026Filed Aug 21, 2026 | Aurora Daljit SinghSee Remarks | Option ExerciseDirect | 67,741 | $1 | $48,774 | Form 4 ↗ |
| Aug 20, 2026Filed Aug 21, 2026 | Aurora Daljit SinghSee Remarks | Open Market SaleDirect | 67,741 | $2 | $102,587 | Form 4 ↗ |
| Aug 20, 2026Filed Aug 21, 2026 | Aurora Daljit SinghSee Remarks | Option ExerciseIndirect | 21,685 | $1 | $15,613 | Form 4 ↗ |
| Aug 20, 2026Filed Aug 21, 2026 | Aurora Daljit SinghSee Remarks | Option ExerciseIndirect | 45,026 | $1 | $32,419 | Form 4 ↗ |
| Aug 20, 2026Filed Aug 21, 2026 | Aurora Daljit SinghSee Remarks | Open Market SaleIndirect | 66,711 | $2 | $101,000 | Form 4 ↗ |
| Aug 20, 2026Filed Aug 21, 2026 | Aurora Daljit SinghSee Remarks | Option ExerciseDirect | 67,741 | $0 | $0 | Form 4 ↗ |
| Aug 20, 2026Filed Aug 21, 2026 | Aurora Daljit SinghSee Remarks | Option ExerciseIndirect | 45,026 | $0 | $0 | Form 4 ↗ |
| Aug 20, 2026Filed Aug 21, 2026 | Aurora Daljit SinghSee Remarks | Option ExerciseIndirect | 21,685 | $0 | $0 | Form 4 ↗ |
| Aug 20, 2026Filed Aug 21, 2026 | Aurora Daljit SinghSee Remarks | Grant Or AwardDirect | 200,000 | $0 | $0 | Form 4 ↗ |